In a significant move reflecting its strategic vision, the company behind the crowdfunding platform "Qing Song Chou," known as Qing Song Health Group, is making strides toward a primary listing on the Hong Kong stock exchangeThis decision follows a major restructuring achieved six months ago, during which Qing Song Chou was separated from another venture, Dor Hospital, allowing the company to streamline its operations.

The deeper impetus behind this restructuring is rooted in Qing Song's previous over-reliance on its insurance sales segment, which, it became clear, did not possess sufficient growth potential to sustain its development in the long runThe company recognized the necessity to pivot its focus squarely onto health services to truly capitalize on future opportunities in the market.

The journey of Qing Song Chou began a decade ago when its founder, Yang Yin, resonated with the notion that every traditional industry warranted a digital revolutionSince its inception in 2014, Qing Song Chou has pioneered a model within the crowdfunding space, blending social media with a community-based approach to fundraising.

Most individuals today are likely familiar with, or have participated in, this type of crowdfunding, largely enabled by social media platforms, where urgent fundraising needs can be met through peer connectionsThis ability to rapidly mobilize a network of supporters has allowed Qing Song Chou to build significant brand recognition and user engagement.

However, the competitive landscape grew more intense following the launch of Qing Song's primary competitor, Shui Di Chou, in 2016. By the end of last year, these platforms, along with another player known as Nuannuan Huimin, were designated by the Ministry of Civil Affairs as key participants within the personal assistance network service realm, highlighting their influential status in this niche market.

Despite being first to market and securing backing from prominent institutions such as Sunshine Insurance, IDG, Tencent, and others, Qing Song Chou has found itself progressively disadvantaged against Shui Di Chou

Advertisements

Speculations regarding potential mergers among crowdfunding platforms have circulated in recent years, particularly suggesting the prospect of Shui Di Chou acquiring Qing Song ChouHowever, the recent IPO application from Qing Song Health Group marks a definitive counter to these rumors while also revealing some rather telling figures regarding their current operational challenges.

As of late 2023, the data suggests stagnation in growth for Qing Song Health GroupThe registered user count stood at 154.6 million by the end of 2022, slightly increasing to 167.8 million by the end of September 2024. Conversely, the active user figures saw a decline from 70.5 million in 2022 to just 50 million in the first three quarters of 2024. This trend signals that while user acquisition may remain high, actual engagement and frequent use of these platforms for fundraising or donations are notably low.

Moreover, the unique characteristics of the Internet crowdfunding market necessitate that users often choose only one platform, creating inherent limitations for companies in this sectorConsequently, well-resourced competitors such as Shui Di Chou—with significant backing from giants like Tencent and Meituan—are increasingly gaining the upper hand.

The pressing challenge for these crowdfunding platforms isn't merely competition; it lies in monetizationWith vast user bases, the big question remains: how to convert these users into tangible revenue? As socially driven platforms, both Shui Di Chou and Qing Song Chou face difficulty in generating significant profits through traditional fundraising commissions due to ongoing scrutiny and controversy surrounding their business models.

Fortunately, after years of trial and error, a viable monetization pathway has emerged: insurance salesThe partnership with Sunshine Insurance has strengthened Qing Song's capabilities in this area, creating avenues for enhanced revenue generationEvery user engaging with Qing Song is, in some sense, motivated by their circumstances to consider insurance—such a mindset creates prime opportunities during moments of fundraising necessity.

As of September 2024, Qing Song Insurance claimed the support of 36 distinct insurance partners, offering a total of 252 products

Advertisements

Over the fiscal years of 2022 and 2023, the revenue generated from this insurance segment reached approximately $321 million and $327 million, respectively, making up significant proportions of the total revenue for Qing Song Health GroupYet, it's worth mentioning that the crisis-driven demand for insurance does introduce questions regarding long-term sustainability.

The ephemeral nature of such revenue proliferation hints at deeper issuesSelling insurance on platforms meant for critical illness fundraising often exploits user anxieties—a tactic that may not lead to lasting brand loyalty given its transactional natureFrom a broader business perspective, this reliance on insurance sales remains a superficial facet of the overall business model; inevitable pressures for user growth undermine long-term prospects as competitive waters grow murky.

The reported annualized premiums from sold insurance products in 2022 and 2023 were $1.3 billion and $1.2 billion, respectively, but earlier declines began to surface as 2023 progressed, with revenues revealing a notable drop of about 3.1% for the first three quarters of 2024 compared to the previous year.

In 2019, Qing Song Chou experienced a transformative rebranding, evolving into Qing Song Health GroupThis new identity encapsulated a diverse portfolio of offerings, including Qing Song Chou for fundraising and Qing Song Insurance, as well as expansions into public welfare initiatives and enhanced health servicesThis strategic pivot aimed to utilize the robust traffic from the crowdfunding space as a springboard for deeper and more meaningful engagement with users.

In the following years, Qing Song Health expanded its services to incorporate early disease screening, health checkups, consultations, medical appointment scheduling, and health product salesA further shift occurred in 2024, with the company formally concluding its restructuring, rigorously divorcing itself from the online fundraising and medical services sectors to focus on its core health service operations.

This restructuring, albeit inducing short-term business pressures, has allowed Qing Song Health Group to sharpen its focus and drive down the dependency on its insurance operations

Advertisements

Advertisements

Advertisements